EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prediction of pathological complete response to neoadjuvant chemotherapy for invasive breast cancers based on longitudinal ultrasound and superb microvascular imaging: a single-center retrospective study

Vorhersage einer pathologischen Komplettremission nach neoadjuvanter Chemotherapie bei invasiven Mammakarzinomen auf Basis longitudinaler Ultraschall- und SMI-Daten: retrospektive Einzelzentrumsstudie

Yanling Zuo, Yongtao Zhan, Jie Zhou, Haoming Xia, Tao Li, Fan Zhou, Chunyue Luo, Huafeng Zeng, Yingjia Li

PeerJ · 14.10.2025 · 13 · e20171

DOI: 10.7717/peerj.20171 ↗

Auf einen Blick

Bei Frauen mit invasivem Mammakarzinom sagte die Kombination aus Ausgangsbefunden und Veränderungen nach 2 NAC-Zyklen eine pCR gut vorher. Das multivariate Modell erreichte eine AUC von 0,963.

Fragestellung

Können Veränderungen in konventionellem Ultraschall und superb microvascular imaging eine pCR nach neoadjuvanter Chemotherapie beim Mammakarzinom vorhersagen?

Methode

Retrospektive Einzelzentrumsstudie bei Frauen mit invasivem Brustkrebs unter NAC von Januar 2022 bis Dezember 2024; Analyse mit logistischer Regression, AUC, Bootstrap und DCA.

Ergebnisse

Die pCR-Gruppe hatte vor NAC häufiger ER- und PR-negative, HER2-positive Tumoren sowie echogene Ränder und kürzere Durchmesser. Nach 2 Zyklen waren ΔVI, ΔSD und SD am stärksten mit pCR assoziiert; AUC 0,963.

Schlussfolgerung der Autor:innen

Ausgangsbefunde von Ultraschall und SMI sowie ihre longitudinalen Veränderungen zeigten eine gute Vorhersageleistung für pCR nach NAC bei Brustkrebs.

Kernaussagen

  • AUC des multivariaten Modells: 0,963
  • ΔVI, ΔSD und SD waren die stärksten Prädiktoren
  • Baseline-US/SMI und Verlaufsänderungen verbesserten die Vorhersage

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 14.10.2025. Verfasst von Yanling Zuo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Breast Neoplasms, Ultrasonography, Mammary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Medical Science and Technology Research Foundation Project.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To examine whether dynamic alterations in conventional ultrasound (US) and superb microvascular imaging (SMI) can act as predictors of pathological complete response (pCR) following neoadjuvant chemotherapy (NAC) in breast cancer (BC).

Methods

This single-center, retrospective study included women with invasive BC who underwent NAC between January 2022 and December 2024. The features of conventional US and SMI characteristics of BC were analyzed before NAC and the change (Δ) after two cycles. Multivariate logistic regression analysis (Forward, Wald, α = 0.05) was used to screen factors independently associated with pCR. Area under the receiver operating characteristic curve (AUC) analysis was performed to confirm the predictive effectiveness and evaluate the internal validity through bootstrap resampling. A nomogram was created to graphically represent the predictive power of the various factors for pCR.

Results

Before NAC, the pCR group exhibited significantly higher negative rates for the estrogen receptor (ER) and progesterone receptor (PR). ( P < 0.001 and P = 0.005, respectively) and significantly higher positive rates of human epidermal growth factor receptor 2 (HER2) and echogenic rinds ( P < 0.001 and P = 0.029, respectively). Additionally, they exhibited significantly shorter largest diameters (LD) and shortest diameters (SD) ( P = 0.001 and P = 0.003). After two cycles of NAC, patients who achieved pCR exhibited a significantly higher proportion of monochrome superb microvascular imaging (mSMI) that had not expanded, as well as disappearance of the echogenic rind ( P < 0.001 and P = 0.002). Regarding the rate of change in LD, SD, and vascular index (VI), patients in the pCR group showed significantly higher values than those in the non-pCR group (all P < 0.001). The multivariate logistic regression model identified ΔVI (%), ΔSD (%), and SD to have the strongest association with pCR. The overall multivariate model demonstrated the best AUC (0.963), which was significantly higher than that of any single factor. Bootstrap resampling, calibration plots, and decision curve analysis (DCA) all demonstrated strong performance in both discrimination and calibration.

Conclusion

The baseline status of US and SMI, as well as the longitudinal changes, demonstrated good predictive performance for pCR in BC following NAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyBreast NeoplasmsUltrasonography, MammaryHumansFemaleRetrospective StudiesMiddle AgedAdultAgedMicrovesselsUltrasonographyChemotherapy, Adjuvant

Stichwörter der Autor:innen

Breast cancerNeoadjuvant chemotherapyPathological complete responseSuperb microvascular imagingUltrasound

Autor:innen und Institutionen

  • Department of Ultrasound, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Ultrasound, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Department of Breast Surgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Department of Radiology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.

Förderung

  • Guangdong Provincial Medical Science and Technology Research Foundation Project

Zitieren

APA

Zuo, Y., Zhan, Y., Zhou, J., Xia, H., Li, T., Zhou, F., Luo, C., Zeng, H., & Li, Y. (2025). Prediction of pathological complete response to neoadjuvant chemotherapy for invasive breast cancers based on longitudinal ultrasound and superb microvascular imaging: a single-center retrospective study. PeerJ, 13, e20171. https://doi.org/10.7717/peerj.20171

Vancouver

Zuo Y, Zhan Y, Zhou J, Xia H, Li T, Zhou F, et al. Prediction of pathological complete response to neoadjuvant chemotherapy for invasive breast cancers based on longitudinal ultrasound and superb microvascular imaging: a single-center retrospective study. PeerJ. 2025;13:e20171. doi:10.7717/peerj.20171

BibTeX
@article{Zuo2025,
  author = {Zuo, Yanling and Zhan, Yongtao and Zhou, Jie and Xia, Haoming and Li, Tao and Zhou, Fan and Luo, Chunyue and Zeng, Huafeng and Li, Yingjia},
  title = {Prediction of pathological complete response to neoadjuvant chemotherapy for invasive breast cancers based on longitudinal ultrasound and superb microvascular imaging: a single-center retrospective study},
  journal = {PeerJ},
  year = {2025},
  volume = {13},
  pages = {e20171},
  doi = {10.7717/peerj.20171}
}
Kostenlos starten →